Contents

Current Pharmaceutical Design, Volume 19 - Number 17



Angiotensin II Type 1 and Type 2 Receptor-induced Cell Signaling

, 19(17): 2988 - 2995

Hiroshi Akazawa, Masamichi Yano, Chizuru Yabumoto, Yoko Kudo-Sakamoto and Issei Komuro


DOI: 10.2174/1381612811319170003








The Physiology and Pathophysiology of a Novel Angiotensin Receptor-binding Protein ATRAP/Agtrap

, 19(17): 3043 - 3048

Kouichi Tamura, Hiromichi Wakui, Akinobu Maeda, Toru Dejima, Masato Ohsawa, Kengo Azushima, Tomohiko Kanaoka, Sona Haku, Kazushi Uneda, Shin-ichiro Masuda, Koichi Azuma, Atsu-ichiro Shigenaga, Yuichi Koide, Yuko Tsurumi-Ikeya, Miyuki Matsuda, Yoshiyuki Toya, Yasuo Tokita, Akio Yamashita and Satoshi Umemura


DOI: 10.2174/1381612811319170010





Chymase Inhibitors

, 19(17): 3065 - 3071

Eiji Yahiro, Shin-ichiro Miura, Satoshi Imaizumi, Yoshinari Uehara and Keijiro Saku


DOI: 10.2174/1381612811319170014





Ezetimibe Therapy for Dyslipidemia: An Update

, 19(17): 3107 - 3114

Niki Katsiki, Eleni Theocharidou, Asterios Karagiannis, Vasilios G. Athyros and Dimitri P. Mikhailidis


DOI: 10.2174/13816128113199990314


Colesevelam: A New and Improved Bile Acid Sequestrant?

, 19(17): 3115 - 3123

Konstantinos Tziomalos, Asterios Karagiannis, Dimitri P. Mikhailidis and Vasilios G. Athyros


DOI: 10.2174/1381612811319170019


The Role of Fibrate Treatment in Dyslipidemia: An Overview

, 19(17): 3124 - 3131

Niki Katsiki, Dragana Nikolic, Giuseppe Montalto, Maciej Banach, Dimitri P. Mikhailidis and Manfredi Rizzo


DOI: 10.2174/1381612811319170020







Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science